Abbott banks on glucose monitors, new launches to ride out China, currency hit
Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...
Larry Magid: Testing prescription, over-the-counter continuous glucose monitors
A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...
Investing7d
Abbott banks on glucose monitors, new launches to ride out China, currency hit
which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor.
The Motley Fool: A diverse health care dynamo
Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...
Vietnam Investment Reviev13d
Abbott's life-changing tech Lingo wins 2025 innovation award
Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device that helps people ...
Why Is Abbott Stock Trading Higher On Thursday?
Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...
eVnExpress on MSN9d
Abbott's Lingo wins 2025 innovation award
Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support ...
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...
Abbott forecasts in line annual profit on medical device sales
Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated ...